Observational Study of Clindamycin Phosphate and Tretinoin Gel for the Treatment of Acne
Ohlson, J.; Dakovic, R.; Berg, M.
Journal of Drugs in Dermatology Jdd 18(4): 328-334
2019
ISSN/ISBN: 1545-9616 PMID: 31012560 Document Number: 17762
INTRODUCTION: Acne vulgaris can cause pain/discomfort and have a negative impact on quality of life (QOL). Clin-RA is an acne treatment consisting of clindamycin phosphate 1.2% and tretinoin 0.025%, which has been proven effective and well tolerated in clinical studies. This prospective, non-interventional study aimed to capture data on previous treatment, acne severity, and QOL in patients with acne treated with Clin-RA and assess the efficacy and tolerability of Clin-RA in routine clinical practice.
Document emailed within 1 workday
Related Documents
Bowman, S.; Gold, M.; Nasir, A.; Vamvakias, G. 2005: Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study Journal of Drugs in Dermatology: Jdd 4(5): 611-618Zeichner, J.A.; Wong, V.; Linkner, R.V.; Haddican, M. 2013: Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris Journal of Drugs in Dermatology: Jdd 12(3): 277-282
Zeichner, J.A.; Patel, R.V.; Haddican, M.; Wong, V. 2012: Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for the treatment of facial acne vulgaris Journal of Drugs in Dermatology: Jdd 11(6): 748-752
Murray, J.; Potts, A. 2014: The phototoxic and photoallergy potential of clindamycin phosphate 1.2%/ tretinoin 0.025% gel for facial acne: results of two single-center, evaluator-blinded, randomized, vehicle-controlled phase 1 studies in healthy volunteers Journal of Drugs in Dermatology: Jdd 13(1): 16-22
Chang, A.L.S.; Alora-Palli, M.; Lima, X.T.; Chang, T.C.; Cheng, C.; Chung, C.M.; Amir, O.; Kimball, A.B. 2012: A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks Journal of Drugs in Dermatology: Jdd 11(3): 333-339
Perez, M.; Aspiolea, F.; De Moragas, J.M. 1987: Comparative double-blind study of topical clindamycin phosphate and oral tetracycline in the treatment of acne Medicina Cutanea Ibero-Latino-Americana 15(3): 173-177
Eichenfield, L.F.; Alió Sáenz, A.B. 2011: Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study Journal of Drugs in Dermatology: Jdd 10(12): 1382-1396
Freeman, S.A.; Moon, S.D.; Spencer, J.M. 2012: Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: summary of a placebo-controlled, double-blind trial Journal of Drugs in Dermatology: Jdd 11(12): 1410-1414
Stoughton, R.B.; Cornell, R.C.; Gange, R.W.; Walter, J.F. 1980: Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris Cutis 26(4): 424-425; 429
Callender, V.D. 2012: Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne Journal of Drugs in Dermatology: Jdd 11(5): 643-648
Amar, L.; Kircik, L.H. 2018: Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel Journal of Drugs in Dermatology: Jdd 17(10): 1107-1112
Cook-Bolden, F.E. 2012: Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel Journal of Drugs in Dermatology: Jdd 11(4): 455-459
Goreshi, R.; Samrao, A.; Ehst, B.D. 2012: A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene Journal of Drugs in Dermatology: Jdd 11(12): 1422-1426
Eichenfield, L.F.; Nighland, M.; Rossi, A.B.; Cook-Bolden, F.; Grimes, P.; Fried, R.; Levy, S.; Barba, A.; Battle, E.; Baumann, L.; Brodell, R.; Bucko, A.; Burkhart, C.; Callender, V.; Cook-Bolden, F.; Dawes, K.; Del Rosso, J.; Dosik, J.; Downie, J.; Eichenfield, L.; English, P.; Forsha, D.; Fowler, J.; Fried, R.; Funicella, T.; Gold, L.; Gold, M.; Grimes, P.; Gross, A.; Kaplan, D.; Kircik, L.; Leyden, J.; Loven, K.; Lucky, A.; Paller, A.; Rafal, E.; Rodriquez, D.; Sadick, N.; Schlessinger, J.; Schiavone, F.; Shavin, J.; Spencer, J.; Spiers, E.; Taylor, S.; Werschler, W.; Wilson, D. 2008: Phase 4 study to assess tretinoin pump for the treatment of facial acne Journal of Drugs in Dermatology: Jdd 7(12): 1129-1136
Leyden, J.; Wortzman, M.; Baldwin, E.K. 2009: Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel Journal of Drugs in Dermatology: Jdd 8(4): 383-388
Webster, G.; Rich, P.; Gold, M.H.; Mraz, S.; Calvarese, B.; Chen, D. 2009: Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations Journal of Drugs in Dermatology: Jdd 8(8): 736-743
Eichenfield, L.F.; Krakowski, A.C. 2012: Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel Journal of Drugs in Dermatology: Jdd 11(7): 818-824
Cullen, S.I.; Childers, R.C. 1988: Tretinoin-sunscreen mixture in the treatment of acne vulgaris Cutis 41(4): 289-291
Brookes, D.B.; Moffitt, R.M.; Sheil, L.P.; Flowers, I.M.; Poulter, G.A. 1978: Comparison of Tretinoin and a composite formulation in the treatment of acne British Journal of Clinical Practice 32(12): 349-352
Yamazaki, M.; Tanabe, K.; Arima, Y.; Matsumoto, Y.; Kimijima, K. 1972: Action of clindamycin-2-phosphate and clindamycin-2-palmitate on the central nervous system Japanese Journal of Antibiotics 25(3): 169-174